These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 323966)

  • 1. [Report on the clinical testing of the delayed-action form of the neuroleptic agent moperone hydrochloride in 20 chronic psychotic patients].
    Lydecken K
    Schweiz Arch Neurol Neurochir Psychiatr; 1977; 120(1):75-82. PubMed ID: 323966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.
    Zwanikken GJ
    Psychiatr Neurol Neurochir; 1973; 76(2):83-92. PubMed ID: 4573494
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical treatment of chronic psychoses with flupenthixol-decanoate (Fluanxol-Depot)].
    Gross H; Kaltenbäck E
    Wien Klin Wochenschr; 1972 Feb; 84(5):80-4. PubMed ID: 5015880
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of schizophrenic psychoses with Lyorodin].
    Schulz HD; Kluge HH; Korda W; Kube B
    Psychiatr Neurol Med Psychol (Leipz); 1977 Jun; 29(6):360-6. PubMed ID: 918199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment with bromperidol in schizophrenic patients].
    Ellerman LA
    Acta Psiquiatr Psicol Am Lat; 1989; 35(1-2):23-30. PubMed ID: 2634329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep analysis during drug-free weekends in chronic schizophrenic patients.
    Jus K; Jus A; Béland C; Bouchard M; Pires P; Fontaine P; Brunelle R
    Biol Psychiatry; 1976 Dec; 11(6):709-18. PubMed ID: 187257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of the delayed-action form of a synthetic antiparkinsonian drug: Akineton].
    Kammerer T; Schweitzer-Bucher E; Jamet P; Royer M
    Ann Med Psychol (Paris); 1972 May; 1(5):688-96. PubMed ID: 5081112
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clozapine in long-term therapy of chronic schizophrenia].
    Gross H; Langner E; Pfolz H
    Arzneimittelforschung; 1974 Jul; 24(7):987-9. PubMed ID: 4408041
    [No Abstract]   [Full Text] [Related]  

  • 9. Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance.
    Singh MM
    Dis Nerv Syst; 1976 Apr; 37(4):191-6. PubMed ID: 767080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Trial of delayed-action neuroleptics in the treatment of acute psychotic conditions].
    Gayral L; Escande M; Fournié H; Perretti A
    Ann Med Psychol (Paris); 1972 Mar; 1(3):381-94. PubMed ID: 5053751
    [No Abstract]   [Full Text] [Related]  

  • 11. An open study with a new long-acting neuroleptic.
    Fleischhauer J; Angst J; Padrutt A; Vetter P
    Act Nerv Super (Praha); 1973 May; 15(2):85-6. PubMed ID: 4752678
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluspirilene, a long-acting injectable neuroleptic.
    Ciccarelli G; Nosé F; Zuanazzi GF
    Acta Psychiatr Belg; 1972 Nov; 72(6):736-47. PubMed ID: 4679675
    [No Abstract]   [Full Text] [Related]  

  • 13. [Time relationship between the appearance of persisting extrapyramidal hyperkineses and psychotic recurrences following sudden interruption of prolonged neuroleptic therapy of chronic schizophrenic patients].
    Degkwitz R; Bauer MP; Gruber M; Hampel G; Luxenburger O; Richartz M; Wenzel W
    Arzneimittelforschung; 1970 Jul; 20(7):890-3. PubMed ID: 4918918
    [No Abstract]   [Full Text] [Related]  

  • 14. [Benzodiazepine monotherapy in acute schizophrenia].
    Jaspert A; Ebert D
    Nervenarzt; 1994 Jan; 65(1):62-5. PubMed ID: 7908419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of treating early-onset malignant schizophrenia with psychotropic drugs and their combinations].
    Sobolev ES; Zaĭtsev SG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(1):114-21. PubMed ID: 6111878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pimozide (orap, R 6238) in residual schizophrenia. A clinical evaluation with long-term double-blind follow-up.
    Denijs EL; Vereecken JL
    Psychiatr Neurol Neurochir; 1973; 76(1):47-59. PubMed ID: 4699105
    [No Abstract]   [Full Text] [Related]  

  • 17. [The place of pyrogen therapy in the modern treatment of schizophrenia patients].
    Malin DI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(3):81-5. PubMed ID: 1332338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of a butyrophenone derivative, methylperidol, in 40 cases of schizophrenia and other psychoses].
    Vinci M
    Osp Psichiatr; 1971; 39(2):399-407. PubMed ID: 4948707
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of the use of fluphenazine in a depot preparation].
    Marcjan K; Pietruszewska I; Wolak E
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():176-82. PubMed ID: 829619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The duration of maintenance therapy in chronic schizophrenia.
    Johnson DA
    Acta Psychiatr Scand; 1976 Apr; 53(4):298-301. PubMed ID: 1274649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.